Core Business Performance - The company's self-developed ventilator products have shown significant growth, becoming a key driver of revenue since late June, with widespread market recognition for their respiratory synchronization and quiet performance [2] - The hearing aid business has focused on improving the operational quality of existing stores, achieving steady growth and significantly reducing losses in the first three quarters [2] - A new generation of bone conduction hearing aids, developed in collaboration with Tencent Cloud, will be officially launched at the Shanghai Import Expo, enhancing voice clarity in noisy environments [2] Overseas and M&A Integration - The company has successfully enhanced the operational efficiency and product competitiveness of Ximaner through the involvement of its core management team and the introduction of quality supply chain resources [3] - The overseas business has maintained rapid growth, with increased customer loyalty and order amounts in the B2B segment, supported by the synergistic effects of acquisitions like Huazhou and Ximaner [3] Strategic Layout - The company will continue to focus on core product categories such as ventilators, hearing aids, and back support devices, leveraging product innovation and channel development to maintain leadership in niche markets [4] - The sales gross margin reached 53.35% in the first three quarters, a 2 percentage point increase year-on-year, driven by scale improvements in core categories and product upgrades [4] - The company plans to launch several new products in the coming year, including a new generation of ventilators and portable oxygen machines [4] Strategic Investment - Recent investments are focused on two main areas: companies specializing in children's hearing screening and intervention, and the integration of brain-machine intelligence with rehabilitation aids to explore new growth areas in intelligent medical and neurotechnology [5]
调研速递|可孚医疗接待民生加银基金等超50家机构 呼吸机成增长引擎 健耳业务近700家门店减亏